critical care management
Recently Published Documents


TOTAL DOCUMENTS

314
(FIVE YEARS 91)

H-INDEX

24
(FIVE YEARS 3)

2022 ◽  
Vol 8 (1) ◽  
pp. 81
Author(s):  
P. Lewis White ◽  
Jan Springer ◽  
Matt P. Wise ◽  
Hermann Einsele ◽  
Claudia Löffler ◽  
...  

The COVID-19 pandemic has resulted in large numbers of patients requiring critical care management. With the established association between severe respiratory virus infection and invasive pulmonary aspergillosis (7.6% for COVID-19-associated pulmonary aspergillosis (CAPA)), the pandemic places a significant number of patients at potential risk from secondary invasive fungal disease. We described a case of CAPA with substantial supporting mycological evidence, highlighting the need to employ strategic diagnostic algorithms and weighted definitions to improve the accuracy in diagnosing CAPA.


2022 ◽  
Vol 25 (S3) ◽  
pp. S230-S240
Author(s):  
Indira Malik ◽  
Rakesh Garg ◽  
Uma R Hariharan

2021 ◽  
pp. 000313482110635
Author(s):  
Julia Riccardi ◽  
Charles J Fredericks ◽  
Rachael A Callcut

The novel coronavirus COVID-19 has been implicated in a number of extra-pulmonary manifestations including rhabdomyolysis. It is hypothesized to be secondary to direct muscle damage from the virus. The usual treatment of rhabdomyolysis is resuscitation with aggressive fluid management to prevent acute renal failure. However, the combination of blunt thoracic trauma and COVID pneumonia has posed additional challenges for critical care management. A 68-year-old male presented to our institution after being found down for an unknown duration of time. He was diagnosed symptomatic COVID pneumonia. His traumatic injuries included 4 rib fractures, a rectus sheath hematoma, and rhabdomyolysis with a creatinine kinase (CK) level of 16,716 U/L. He was initially treated with steroids, prone positioning, and aggressive fluid administration. Despite treatment his CK level peaked at 146,328 U/L. Here we present the case of trauma and COVID-induced rhabdomyolysis with an extremely elevated CK level.


Author(s):  
Andrei-Petru Paraschiv ◽  
Jean-Christophe Cejka ◽  
Marc Lilot ◽  
Luc Aigle ◽  
Jean-Jacques Lehot ◽  
...  

2021 ◽  
Vol 3 (12) ◽  
pp. e0587
Author(s):  
Alexander J. Parker ◽  
Monalisa Mishra ◽  
Pooja Tiwary ◽  
Mike Sharman ◽  
Manu Priya-Sharma ◽  
...  

2021 ◽  
pp. 139-165
Author(s):  
Adel E. Ahmed Ganaw ◽  
Sohel Mohamed Gamal Ahmed ◽  
Moad Ehfeda ◽  
Sirajeddin Belkhair

Author(s):  
Vorakamol Phoophiboon ◽  
Monvasi Pachinburavan ◽  
Nicha Ruamsap ◽  
Natthawan Sanguanwong ◽  
Nattapong Jaimchariyatam

2021 ◽  
Vol 107 (11) ◽  
pp. 529-533
Author(s):  
Eyrún Anna Kristinsdóttir ◽  
◽  
Sigrún Ásgeirsdóttir ◽  
Halldór Skúlason ◽  
Aron Björnsson ◽  
...  

Spontaneous subarachnoid haemorrhage is characterized by extravasation of blood into the subarachnoid space without a preceding trauma. The leading cause is a ruptured intracranial aneurysm. Serious neurologic complications can occur, such as rebleeding, cerebral vasospasm and delayed cerebral ischemia. Subarachnoid haemorrhage is a serious condition with a high mortality rate and those who survive often suffer long-term consequences. Prevention of rebleeding by aneurysm repair is essential and guidelines recommend this procedure should be done as soon as possible or within 72 hours. Management requires intensive care with emphasis on accurate blood pressure control, maintaining normal fluid and electrolyte balance and monitoring the level of consciousness. All patients should be treated with the calcium channel blocker nimodipine to reduce the risk of vasospasm and delayed cerebral ischemia which are among the most serious complications of subarachnoid haemorrhage.


Author(s):  
Nidhi Gupta ◽  
Bhavna Gupta ◽  
Venkatesh S. Pai

Acute myeloid leukaemia (AML) is a highly heterogeneous disorder and is characterised by the proliferation of poorly differentiated myeloid cells due to underlying mutation, eventually causing bone marrow failure. Accounting for approximately 25% of cases, AML is the most frequent form of leukaemia in the world yet has the lowest survival rate among all leukaemias. Patients with haematological malignancy are more susceptible to severe acute respiratory syndrome coronavirus-2 infection and further development of severe infection, including pneumonia with poor blood oxygenation. The management of such patients is more challenging than expected. Successful management of one such case is discussed in this report. COVID-19 infection can cause great harm to a patient with underlying leukaemia and increase the mortality risk. It has a major impact on the physical and psychological health of the patient. Therefore, these patients need special care and attention. The authors emphasise the importance of supportive management (oxygen with bilevel positive airway pressure, prone positioning, and physiotherapy) to prevent complications.


Sign in / Sign up

Export Citation Format

Share Document